Table 2.

Incidence of CMV Infection and CMV Disease

Antigenemia Culture CMV Disease Deaths
CD34-selected PBSC  
 Screening* 19  5 (26.3%) 1 (5.3%)  3 (15.8%)  1 (5.3%)  
 No screening  12   4 (33.3%)  3 (25%)  
 Total  31   7 (22.6%)  4 (12.9%)  
Unselected PBSC 
 Screening* 172  30 (17.4%)  4 (2.3%)  5 (2.9%) 3 (1.7%)  
 No screening  65    5 (7.7%) 2 (3.1%)  
 Total  237    10 (4.2%) 5 (2.1%) 
Antigenemia Culture CMV Disease Deaths
CD34-selected PBSC  
 Screening* 19  5 (26.3%) 1 (5.3%)  3 (15.8%)  1 (5.3%)  
 No screening  12   4 (33.3%)  3 (25%)  
 Total  31   7 (22.6%)  4 (12.9%)  
Unselected PBSC 
 Screening* 172  30 (17.4%)  4 (2.3%)  5 (2.9%) 3 (1.7%)  
 No screening  65    5 (7.7%) 2 (3.1%)  
 Total  237    10 (4.2%) 5 (2.1%) 
*

Weekly CMV screening.

Close Modal

or Create an Account

Close Modal
Close Modal